← SynDRA
BARASERTIB
SynDRA canonical compound SYN0006392 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | AURKB |
|---|
| Mechanism of action | Aurora kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- aurora kinase inhibitor
- AURKB INHIBITOR
- Serine/threonine-protein kinase Aurora-B inhibitor
- AURKA INHIBITOR
- AURKB MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- NUAK2
- PDGFRA
- PAK6
- PAK4
- PAK2
- PAICS
- OPA1
- OLA1
- NTRK3
- PRKCA
- NTRK2
- NTRK1
- NQO2
- NLK
- NEK9
- NEK3
- NEK2
- PDGFRB
- PDXK
- PEBP1
- PFKP
- PRKAG2
- PRKAG1
- PRKACG
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PKN2
- PKN1
- PKMYT1
- PIP4K2C
- PIP4K2A
- PIM1
- PHKG2
- PGRMC1
- NEK1
- NDUFA13
- NAT10
Cross-references
Synonyms
- AZD-1152
- BARASERTIB (WHO-DD)
- AZD-2811
- AZD1152
- AZD1152-HQPA
- barasertibum
- RefChem:916707
- DTXCID30145074
- Aurora Kinase Inhibitor AZD1152
- AZD 1152
- Barasertib [INN]
- Barasertib (who-dd)
- BARASERTIB [WHO-DD]
- AZD1152 Trifluoroacetic Acid Salt
- UNII-16XC2U7W8N
- MFCD15146330
- Kinome_3324
- Azd1152 trifluoroacetic acid
- SCHEMBL613582
- C26H31FN7O6P
- GTPL7332
- orb1707614
- SCHEMBL16671950
- SCHEMBL29368256
- SCHEMBL29720420
- CHEBI:167636
- GLXC-90119
- HMS3674C21
- HMS3747E05
- AZD1152?
- CS-D0326
- EX-A3656
- HNB88103
- AZD1152-HQPA dihydrogen phosphate
- BDBM50241089
- NSC799355
- AKOS022175627
- AKOS040741193
Look up BARASERTIB in the interactive SynDRA portal →